Abvc Biopharma Inc (ABVC)

Finanzdaten der Abvc Biopharma Inc-Aktie (ABVC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	50.43%0.78	1.57	2.20	1.96	2.29
Selling, General, and Administrative	33.01%0.50	0.75	0.78	0.80	0.69
Research and Development	31.40%0.02	0.03	0.03	0.03	0.03
Operating Income/Loss	50.43%-0.78	-1.57	-2.99	-1.96	-2.29
Nonoperating Income/Loss	73.65%-0.03	-0.12	-0.82	-0.12	-0.01
Income/Loss From Equity Method Investments	21.17%-0.02	-0.03	-0.65	-0.05	-0.04
Income/Loss From Continuing Operations Before Tax	52.04%-0.81	-1.69	-3.81	-2.08	-2.31
	52.04%-0.81	-1.69	-3.81	-2.08	-2.33
Attributable To Parent	52.77%-0.74	-1.56	-3.56	-2.04	-2.26
Attributable To Noncontrolling Interest	43.29%-0.07	-0.13	-0.25	-0.04	-0.08
Basic Average Shares	2.40%26.06	25.45	1.54	23.26	17.39
Diluted Average Shares	2.40%26.06	25.45	1.54	23.26	17.39
Basic Earnings Per Share	50.00%-0.03	-0.06	-0.16	-0.09	-0.13
Diluted Earnings Per Share	50.00%-0.03	-0.06	-0.16	-0.09	-0.13